Last reviewed · How we verify
NCT05834309: SMI01
Exercise Effects on Health Status in Patients With Severe Mental Illness
NA trial testing Physical exercise in Exercise in 100 participants. Currently enrolling.
5 May 2025
Quick facts
| Lead sponsor | Universidad Pública de Navarra |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 5 December 2022 |
| Primary completion | 5 May 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 2 locations across Spain |
Drugs / interventions tested
- Physical exercise
Conditions studied
- Exercise — all drugs for Exercise →
- Metabolic Syndrome — all drugs for Metabolic Syndrome →
- Mental Disorders, Severe — all drugs for Mental Disorders, Severe →
- Severe Mental Disorder — all drugs for Severe Mental Disorder →
Sponsor
Universidad Pública de Navarra
Who can join
Adults 18 to 65, any sex, with Exercise or Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
People with severe mental disorders have a mortality rate 2 to 3 times higher than that of the general population, largely due to the presence of comorbidities, with a predominance of cardiovascular disease. This population has a higher risk of developing metabolic syndrome compared to the healthy population. Several factors are involved. The usual pharmacological treatment in people with severe mental disorder is a risk factor for the development of metabolic syndrome and deterioration of physical condition. This is generally compounded by poor health care, high-calorie diets, a sedentary lifestyle, difficulties in coping with life situations that generate emotional states (anxiety and/or depression) that result in unhealthy lifestyle habits related to food, activity, interpersonal relationships, sleep, consumption habits (tobacco, alcohol and drugs) and other environmental factors. Physical exercise has been proposed as one of the most effective treatments to reverse the negative consequences of low levels of physical activity in this population. However, the mechanism of action of exercise on health status and the optimal "dose" and intensity of exercise to achieve the greatest number of benefits with respect to cardiometabolic health in patients with severe mental disorder are unknown.The study will be carried out at the Mental Health Rehabilitation Unit of Navarra, a center under the Mental Health Management of Osasunbidea, where people between 18 and 65 years of age with a diagnosis of severe mental illness in a situation of clinical stability receive treatment.The sample will be composed of 100 participants from consecutive admissions to the Rehabilitation Unit. The subjects will be randomized into 2 groups; a control group that will receive the usual specialized care and an intervention group, which in addition to receiving the usual rehabilitation treatment, will undergo a 6-week multicomponent physical exercise program performed 2 days per week. The effects of exercise on the inflammatory profile, metabolic parameters, physical condition, cognitive function, vascular function, muscle strength, health-related quality of life, lifestyle habits (diet, activation, sleep, substance use) and mood will be evaluated.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05834309
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Physical exercise
Trials testing the same drug.
- NCT07397910 — Clinical Trial on a Natural Compound to Improve Chronic Inflammation After SARS-CoV-2 Infection · NA · not yet recruiting
- NCT06952166 — Understanding the Psychological Benefits and Neurophysiological Mechanisms of Qigong in Older Adults · NA · not yet recruiting
- NCT06846788 — Study of Nerve Injuries and Physical Exercise · NA · not yet recruiting
- NCT04488159 — Immunoscore As Decision Guidance for Adjuvant Chemotherapy in Colon Cancer · Phase 3 · withdrawn
- NCT06634316 — Sarcopenia in Patients With Heart Failure · NA · active not recruiting
Other recruiting trials for Exercise
Currently open trials in the same condition.
- NCT07504068 — Effects of Physical Exercise and a Nutritional Supplement on Body Composition, Metabolic Function, and Overall Health in · NA · recruiting
- NCT07479940 — Obesity and Aging: Impacts of Nutritional Counseling and Physical Exercise on Telomeres and Senescence Parameters · NA · active not recruiting
- NCT07498530 — Virtual Assistant for Exercise Adherence in Older ADULTS · NA · recruiting
- NCT07426172 — Role of Elevated Lactate Levels on Lipid and Carbohydrate Metabolism. · NA · recruiting
- NCT07276477 — Inspiratory Muscle Training After Stroke · NA · recruiting
Other Universidad Pública de Navarra trials
Trials by the same sponsor.
- NCT07264231 — Exercise During Pregnancy: Effects on the Maternal-Fetal Unit · NA · enrolling by invitation
- NCT07374900 — Hybrid Versus Fully In-person Physiotherapy for Non-traumatic Shoulder Pain in Routine Care. · completed
- NCT07301671 — Prospective Cohort of Digital Shoulder Rehabilitation Using the REHABI System in Routine Clinical Practice · completed
- NCT07251361 — Effects of a Multicomponent Training Program on Cardiac Function, Skeletal Muscle Metabolism, Functional Capacity, and Q · NA · enrolling by invitation
- NCT05741879 — Gamified Family-based Health Exercise Intervention to Improve Adherence to 24-h Movement Behaviors Recommendations in Ch · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05834309 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Pública de Navarra
- Last refreshed: 8 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05834309.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing